MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines On-Demand Webinar MIDD 策略在临床前和临床转化中的应用:临床药理学家与建模学科的合作 Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.Certara2025 年 7 月 29 日
Boosting Confidence in Drug Discovery with PBPK On-Demand Webinar 通过 PBPK 模型提升药物发现的信心 Explore Simcyp Discovery Version 2 updates to boost early-stage drug development.Certara2025 年 7 月 25 日
AusBiotech International Conference 2025 Conference AusBiotech International Conference 2025 Certara2025 年 7 月 25 日
The end of animal testing? Transitioning to models is promising — but no silver bullet Press Coverage 动物实验的终结?转向模型研究充满希望,但并非万能良方 The FDA has stated that the pharma industry must transition to using in vitro assays,…Certara2025 年 7 月 21 日
Certara’s Simcyp Educational Webinar Series Part 3: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling & Simulation Approaches [in Japanese] On-Demand Webinar Certara Simcyp 教育网络研讨会系列第 3 部分:利用建模与模拟方法理解消化道中的过饱和溶解现象[日语] Learn PBBM fundamentals and supersaturated dissolution modeling in Japanese with Dr. Kambayashi—ideal for CMC and…Certara2025 年 7 月 16 日
制药行业是如何应对全球健康不平等问题的? 新闻报导 制药行业是如何应对全球健康不平等问题的? Explore Karen Rowland Yeo's insights on using Model-Informed Drug Development to address global health equities…Certara2025 年 6 月 17 日
Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance On-Demand Webinar 模型引导的药物开发(MIDD)的监管环境演变:ICH M15 指南草案的影响 We explore the evolving regulatory landscape for Model-Informed Drug Development (MIDD), focusing on the impact…Certara2025 年 5 月 23 日
Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model? 网络研讨会点播 Certara Simcyp 教育网络研讨会系列:PBBM 从入门到精通第 2 部分:什么是药物吸收模型? Part 3 in November: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling &…Certara2025 年 5 月 12 日
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions On-Demand Webinar Adagrasib 药物相互作用的临床与基于生理的药代动力学模型评估 Director, Clinical Pharmacology, ORIC Pharmaceuticals SVP, Head of Simcyp PBPK Modeling Services, Certara Director, PBPK…Certara2025 年 4 月 21 日
Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy Case Study 通过 PBPK 模型推动儿童癫痫个性化治疗 See how PBPK modeling enabled precise, individualized dosing for children with rare neurodevelopmental disorders, helping…Certara2025 年 4 月 16 日